An update on clinical utility of rilpivirine in the management of HIV infection in treatment-naïve patients
Opass Putcharoen,1–3 Stephen J Kerr,4 Kiat Ruxrungtham2,4,5 1Division of Infectious Diseases, Department of Medicine, Chulalongkorn University, 2Faculty of Medicine, King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Chulalongkorn University, 3Center of Excellence for Infectious...
Guardado en:
Autores principales: | Putcharoen O, Kerr SJ, Ruxrungtham K |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ec33a39843224dbd9b05ab35b8bbfda7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Optimizing management of treatment-naïve and treatment-experienced HIV+ patients: the role of maraviroc
por: Eva Poveda, et al.
Publicado: (2010) -
Combination therapies, effectiveness, and adherence in patients with HIV infection: clinical utility of a single tablet of emtricitabine, rilpivirine, and tenofovir
por: Wainberg MA
Publicado: (2013) -
Dolutegravir/rilpivirine for the treatment of HIV-1 infection
por: Dowers E, et al.
Publicado: (2018) -
Poor immunological recovery among severely immunosuppressed antiretroviral therapy-naïve Ugandans
por: Nanzigu S, et al.
Publicado: (2013) -
New option for management of HIV-1 infection in treatment-naive patients: once-daily, fixed-dose combination of rilpivirine-emtricitabine-tenofovir
por: Patel N, et al.
Publicado: (2012)